15:58 Wed 06 Jan 2021
Tissue Regenix Group - PDMR Dealings
Tissue Regenix Group plc
PDMR Dealings
Leeds,
Following this purchase,
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.
For more Information:
Tissue Regenix Group plc |
Tel: 0330 430 3052 |
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker) |
Tel: 0207 710 7600
|
About Tissue Regenix
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.
In
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
|
Details of the person discharging managerial responsibilities / person closely associated |
|
a)
|
Names |
|
2
|
Reason for the notification |
|
a)
|
Position/status
|
Independent Non-Executive Director |
b)
|
Initial notification /Amendment
|
Initial notification |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a)
|
Name
|
Tissue Regenix Group plc |
b)
|
LEI |
213800PNOD5UHQUFJI36 |
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a)
|
Description of the financial instrument, type of instrument
|
Ordinary Shares of 0.1p each |
b) |
Identification code
|
GB00B5SGVL29 |
c)
|
Nature of the transaction
|
Purchase of Ordinary Shares |
d)
|
Price(s) and volume(s) |
Volume(s): 2,777,770 Ordinary Shares Price: 0.54 pence per Ordinary Share |
d)
|
Aggregated information - Aggregated volume - Price |
N/A |
e)
|
Date of the transactions |
|
f)
|
Place of the transaction |
AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE